A network approach reveals roles for cancer stem cells in cancer promotion
We talked to team PROMINENT members Professor Allan Balmain and Dr Mark Taylor from the University of California San Francisco about their latest paper ‘Stem-cell states converge in multi-stage cutaneous squamous cell carcinoma development…
We are pleased to welcome Dr Tom Misteli of the National Cancer Institute’s Center for Cancer Research, USA, to the Cancer Grand Challenges Scientific Committee. Tom will join the other 14 members of the Scientific…
We are pleased to welcome seven new members to the Cancer Grand Challenges Advocacy Panel: Yelak Biru, Ivana Cattaneo, Anjee Davies, Joya Harris, Dirk Hellrung, Chris Stewart and Christine Wu.
From helping to shape…
New research from the Cancer Grand Challenges CANCAN team finds that a ketogenic diet slows tumour growth but shortens survival by accelerating the onset of cancer cachexia in murine models. The findings, published in…
New research from the Cancer Grand Challenges PRECISION team, published in Scientific Reports, finds that the crystallographic and chemical features of microcalcifications present in ductal carcinoma in situ (DCIS)…
A new Nature paper from the Cancer Grand Challenges SPECIFICANCER team describes a mechanism through which oestrogen-induced DNA breaks and their repair by inter-chromosomal translocations initiate a cascade of events…
In March 2023, we launched nine new challenges, with up to £20m funding for global research teams. This webinar features everything you need to know about the Cancer Grand Challenges application process
Hosted by…
Members of our Scientific Committee discuss each of our nine new challenges, their potential impact and what we're looking for from applications
Ageing and cancer
Cancer cell plasticity
Cancer inequities…
In an ‘In Focus’ commentary article for AACR Cancer Discovery, Dr David Scott and Dr Dinah Singer discuss our nine new Cancer Grand Challenges, for which Expressions of Interest are open until 22 June 2023.
In March at…
Members of the Cancer Grand Challenges PRECISION team have developed a living biobank of 115 patient-derived Mouse-INtraDuctal (MIND) ductal carcinoma in situ (DCIS) models and used them to identify risk factors…